Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 2
2001 1
2003 2
2004 1
2005 1
2007 1
2008 3
2010 2
2011 2
2012 4
2013 3
2014 4
2015 3
2016 7
2017 4
2018 8
2019 4
2020 7
2021 8
2022 8
2023 6
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis Carcinoma.
Kroening G, Luo J, Evans MG, Adeyelu T, Ou SI, Arter ZL, Wise-Draper TM, Sukari A, Azmi AS, Braxton DR, Elliott A, Bryant DA, Oberley MJ, Kim C, Shapiro GI, French CA, Nagasaka M. Kroening G, et al. Among authors: french ca. JCO Precis Oncol. 2024 Oct;8:e2400334. doi: 10.1200/PO.24.00334. Epub 2024 Oct 24. JCO Precis Oncol. 2024. PMID: 39447095 Free PMC article.
Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.
Luo J, Sanchez M, Lee E, Hertzler H, Luong N, Mazzola E, Finstein B, Tamen R, Brisbane G, Nguyen T, Paik PK, Chaft JE, Cheng ML, Khalil H, Piha-Paul SA, Sholl LM, Nishino M, Jänne PA, DuBois SG, Hanna GJ, Shapiro GI, French CA. Luo J, et al. Among authors: french ca. J Thorac Oncol. 2024 May;19(5):829-838. doi: 10.1016/j.jtho.2023.12.022. Epub 2023 Dec 27. J Thorac Oncol. 2024. PMID: 38154515
The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
Durall RT, Huang J, Wojenski L, Huang Y, Gokhale PC, Leeper BA, Nash JO, Ballester PL, Davidson S, Shlien A, Sotirakis E, Bertaux F, Dubus V, Luo J, Wu CJ, Keskin DB, Eagen KP, Shapiro GI, French CA. Durall RT, et al. Among authors: french ca. Cancer Res. 2023 Dec 1;83(23):3846-3860. doi: 10.1158/0008-5472.CAN-23-2545. Cancer Res. 2023. PMID: 37819236 Free PMC article.
EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes.
Huang Y, Durall RT, Luong NM, Hertzler HJ, Huang J, Gokhale PC, Leeper BA, Persky NS, Root DE, Anekal PV, Montero Llopis PDLM, David CN, Kutok JL, Raimondi A, Saluja K, Luo J, Zahnow CA, Adane B, Stegmaier K, Hawkins CE, Ponne C, Le Q, Shapiro GI, Lemieux ME, Eagen KP, French CA. Huang Y, et al. Among authors: french ca. Cancer Res. 2023 Dec 1;83(23):3956-3973. doi: 10.1158/0008-5472.CAN-23-1475. Cancer Res. 2023. PMID: 37747726 Free PMC article.
EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes.
Huang Y, Durall RT, Luong NM, Hertzler HJ, Huang J, Gokhale PC, Leeper BA, Persky NS, Root DE, Anekal PV, Montero Llopis PDLM, David CN, Kutok JL, Raimondi A, Saluja K, Luo J, Zahnow CA, Adane B, Stegmaier K, Hawkins CE, Ponne C, Le Q, Shapiro GI, Lemieux ME, Eagen KP, French CA. Huang Y, et al. Among authors: french ca. bioRxiv [Preprint]. 2023 Aug 16:2023.08.15.553204. doi: 10.1101/2023.08.15.553204. bioRxiv. 2023. Update in: Cancer Res. 2023 Dec 1;83(23):3956-3973. doi: 10.1158/0008-5472.CAN-23-1475 PMID: 37645799 Free PMC article. Updated. Preprint.
Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation.
Cheng ML, Huang Y, Luong N, LoPiccolo J, Nishino M, Sholl LM, Chirieac LR, Santucci AD, Rabin MS, Jänne PA, Coker S, Diamond JR, Hilton J, Shapiro GI, French CA. Cheng ML, et al. Among authors: french ca. JCO Precis Oncol. 2023 Jun;7:e2200633. doi: 10.1200/PO.22.00633. JCO Precis Oncol. 2023. PMID: 37384867 Free PMC article. No abstract available.
NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA, Gilday SD, Afkhami M, Bell D, Bocklage T, Boisselier P, Chau NG, Cipriani NA, Costes-Martineau V, Ghossein RA, Hertzler HJ, Kramer AM, Limaye S, Lopez CA, Ng TL, Weissferdt A, Xu B, Zhang S, French CA. Barletta JA, et al. Among authors: french ca. Am J Surg Pathol. 2022 Dec 1;46(12):1706-1715. doi: 10.1097/PAS.0000000000001967. Epub 2022 Aug 29. Am J Surg Pathol. 2022. PMID: 36040068 Free PMC article.
NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF, Oliveira TB, Hertzler H, Toledo RN, D'Almeida Costa F, Lopes Pinto CA, Nunes WA, Nascimento AF, French CA, Nascimento AG. Abreu RF, et al. Among authors: french ca. Hum Pathol. 2022 Aug;126:87-99. doi: 10.1016/j.humpath.2022.05.015. Epub 2022 May 24. Hum Pathol. 2022. PMID: 35623465
Report of the First International Symposium on NUT Carcinoma.
French CA, Cheng ML, Hanna GJ, DuBois SG, Chau NG, Hann CL, Storck S, Salgia R, Trucco M, Tseng J, Stathis A, Piekarz R, Lauer UM, Massard C, Bennett K, Coker S, Tontsch-Grunt U, Sos ML, Liao S, Wu CJ, Polyak K, Piha-Paul SA, Shapiro GI. French CA, et al. Clin Cancer Res. 2022 Jun 13;28(12):2493-2505. doi: 10.1158/1078-0432.CCR-22-0591. Clin Cancer Res. 2022. PMID: 35417004 Free PMC article.
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein in testis carcinoma and other cancers: Results of a Phase I/II open-label, dose escalation study.
Cousin S, Blay JY, Garcia IB, de Bono JS, Le Tourneau C, Moreno V, Trigo J, Hann CL, Azad AA, Im SA, Cassier PA, French CA, Italiano A, Keedy VL, Plummer R, Sablin MP, Hemming ML, Ferron-Brady G, Wyce A, Khaled A, Datta A, Foley SW, McCabe MT, Wu Y, Horner T, Kremer BE, Dhar A, O'Dwyer PJ, Shapiro GI, Piha-Paul SA. Cousin S, et al. Among authors: french ca. Int J Cancer. 2022 Mar 15;150(6):993-1006. doi: 10.1002/ijc.33861. Epub 2021 Nov 26. Int J Cancer. 2022. PMID: 34724226 Clinical Trial.
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG, Noguchi M, Nonaka D, Papotti MG, Porubsky S, Sholl LM, Tateyama H, Thomas de Montpréville V, Travis WD, Rajan A, Roden AC, Ströbel P. Marx A, et al. Among authors: french ca. J Thorac Oncol. 2022 Feb;17(2):200-213. doi: 10.1016/j.jtho.2021.10.010. Epub 2021 Oct 22. J Thorac Oncol. 2022. PMID: 34695605 Free article. Review.
Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.
Shiota H, Alekseyenko AA, Wang ZA, Filic I, Knox TM, Luong NM, Huang Y, Scott DA, Jones KL, Gokhale PC, Lemieux ME, Cole PA, Kuroda MI, French CA. Shiota H, et al. Among authors: french ca. Mol Cancer Res. 2021 Nov;19(11):1818-1830. doi: 10.1158/1541-7786.MCR-21-0259. Epub 2021 Jul 20. Mol Cancer Res. 2021. PMID: 34285087 Free PMC article.
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE.
Pearson AD, DuBois SG, Buenger V, Kieran M, Stegmaier K, Bandopadhayay P, Bennett K, Bourdeaut F, Brown PA, Chesler L, Clymer J, Fox E, French CA, Germovsek E, Giles FJ, Bender JG, Hattersley MM, Ludwinski D, Luptakova K, Maris J, McDonough J, Nikolova Z, Smith M, Tsiatis AC, Vibhakar R, Weiner S, Yi JS, Zheng F, Vassal G. Pearson AD, et al. Among authors: french ca. Eur J Cancer. 2021 Mar;146:115-124. doi: 10.1016/j.ejca.2021.01.018. Epub 2021 Feb 16. Eur J Cancer. 2021. PMID: 33601323 Free article. Review.
Supercharging BRD4 with NUT in carcinoma.
Eagen KP, French CA. Eagen KP, et al. Among authors: french ca. Oncogene. 2021 Feb;40(8):1396-1408. doi: 10.1038/s41388-020-01625-0. Epub 2021 Jan 15. Oncogene. 2021. PMID: 33452461 Free PMC article. Review.
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma.
Shapiro GI, LoRusso P, Dowlati A, T Do K, Jacobson CA, Vaishampayan U, Weise A, Caimi PF, Eder JP, French CA, Labriola-Tompkins E, Boisserie F, Pierceall WE, Zhi J, Passe S, DeMario M, Kornacker M, Armand P. Shapiro GI, et al. Among authors: french ca. Br J Cancer. 2021 Feb;124(4):744-753. doi: 10.1038/s41416-020-01180-1. Epub 2020 Dec 14. Br J Cancer. 2021. PMID: 33311588 Free PMC article. Clinical Trial.
Nuclear protein in testis midline carcinoma in a Turkish boy: a case report.
Bayrak BY, Yildiz DK, Demirsoy U, Çorapçioğlu F, Anik Y, French CA. Bayrak BY, et al. Among authors: french ca. Asian Biomed (Res Rev News). 2020 Oct 31;14(5):203-208. doi: 10.1515/abm-2020-0029. eCollection 2020 Oct. Asian Biomed (Res Rev News). 2020. PMID: 37551266 Free PMC article.
Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734.
Morrison-Smith CD, Knox TM, Filic I, Soroko KM, Eschle BK, Wilkens MK, Gokhale PC, Giles F, Griffin A, Brown B, Shapiro GI, Zucconi BE, Cole PA, Lemieux ME, French CA. Morrison-Smith CD, et al. Among authors: french ca. Mol Cancer Ther. 2020 Jul;19(7):1406-1414. doi: 10.1158/1535-7163.MCT-20-0087. Epub 2020 May 5. Mol Cancer Ther. 2020. PMID: 32371576
An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.
Chau NG, Ma C, Danga K, Al-Sayegh H, Nardi V, Barrette R, Lathan CS, DuBois SG, Haddad RI, Shapiro GI, Sallan SE, Dhar A, Nelson JJ, French CA. Chau NG, et al. Among authors: french ca. JNCI Cancer Spectr. 2019 Nov 6;4(2):pkz094. doi: 10.1093/jncics/pkz094. eCollection 2020 Apr. JNCI Cancer Spectr. 2019. PMID: 32328562 Free PMC article.
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.
Piha-Paul SA, Hann CL, French CA, Cousin S, Braña I, Cassier PA, Moreno V, de Bono JS, Harward SD, Ferron-Brady G, Barbash O, Wyce A, Wu Y, Horner T, Annan M, Parr NJ, Prinjha RK, Carpenter CL, Hilton J, Hong DS, Haas NB, Markowski MC, Dhar A, O'Dwyer PJ, Shapiro GI. Piha-Paul SA, et al. Among authors: french ca. JNCI Cancer Spectr. 2019 Nov 6;4(2):pkz093. doi: 10.1093/jncics/pkz093. eCollection 2020 Apr. JNCI Cancer Spectr. 2019. PMID: 32328561 Free PMC article.
Metastatic Basal Cell Carcinoma.
Laga AC, Schaefer IM, Sholl LM, French CA, Hanna J. Laga AC, et al. Among authors: french ca. Am J Clin Pathol. 2019 Nov 4;152(6):706-717. doi: 10.1093/ajcp/aqz089. Am J Clin Pathol. 2019. PMID: 31355851 Free PMC article.
A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma.
Diolaiti D, Dela Cruz FS, Gundem G, Bouvier N, Boulad M, Zhang Y, Chou AJ, Dunkel IJ, Sanghvi R, Shah M, Geiger H, Rahman S, Felice V, Wrzeszczynski KO, Darnell RB, Antonescu CR, French CA, Papaemmanuil E, Kung AL, Shukla N. Diolaiti D, et al. Among authors: french ca. Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6):a003194. doi: 10.1101/mcs.a003194. Print 2018 Dec. Cold Spring Harb Mol Case Stud. 2018. PMID: 30552129 Free PMC article.
Spindle Cell Nuclear in Testis Carcinoma of the Lung: A Challenging Tumor.
Pelosi G, Cannone M, Balladore E, Rahal D, Bossi P, Novellis P, Bottoni E, Toschi L, Roncalli M, French CA, Veronesi G. Pelosi G, et al. Among authors: french ca. J Thorac Oncol. 2019 Feb;14(2):311-313. doi: 10.1016/j.jtho.2018.11.010. Epub 2018 Nov 23. J Thorac Oncol. 2019. PMID: 30476575 Free article. No abstract available.
Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).
Strickland KC, Eszlinger M, Paschke R, Angell TE, Alexander EK, Marqusee E, Nehs MA, Jo VY, Lowe A, Vivero M, Hollowell M, Qian X, Wieczorek T, French CA, Teot LA, Cibas ES, Lindeman NI, Krane JF, Barletta JA. Strickland KC, et al. Among authors: french ca. Endocr Pathol. 2018 Mar;29(1):68-74. doi: 10.1007/s12022-018-9515-x. Endocr Pathol. 2018. PMID: 29396809
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.
Brägelmann J, Dammert MA, Dietlein F, Heuckmann JM, Choidas A, Böhm S, Richters A, Basu D, Tischler V, Lorenz C, Habenberger P, Fang Z, Ortiz-Cuaran S, Leenders F, Eickhoff J, Koch U, Getlik M, Termathe M, Sallouh M, Greff Z, Varga Z, Balke-Want H, French CA, Peifer M, Reinhardt HC, Örfi L, Kéri G, Ansén S, Heukamp LC, Büttner R, Rauh D, Klebl BM, Thomas RK, Sos ML. Brägelmann J, et al. Among authors: french ca. Cell Rep. 2017 Sep 19;20(12):2833-2845. doi: 10.1016/j.celrep.2017.08.082. Cell Rep. 2017. PMID: 28930680 Free PMC article.
Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.
Alekseyenko AA, Walsh EM, Zee BM, Pakozdi T, Hsi P, Lemieux ME, Dal Cin P, Ince TA, Kharchenko PV, Kuroda MI, French CA. Alekseyenko AA, et al. Among authors: french ca. Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4184-E4192. doi: 10.1073/pnas.1702086114. Epub 2017 May 8. Proc Natl Acad Sci U S A. 2017. PMID: 28484033 Free PMC article.
NUT midline carcinoma of the larynx: an international series and review of the literature.
Hellquist H, French CA, Bishop JA, Coca-Pelaz A, Propst EJ, Paiva Correia A, Ngan BY, Grant R, Cipriani NA, Vokes D, Henrique R, Pardal F, Vizcaino JR, Rinaldo A, Ferlito A. Hellquist H, et al. Among authors: french ca. Histopathology. 2017 May;70(6):861-868. doi: 10.1111/his.13143. Epub 2017 Feb 21. Histopathology. 2017. PMID: 27926786 Free PMC article. Review.
Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, Hsi P, Bauer DE, Lathan CS, Rodriguez-Galindo C, Tishler RB, Haddad RI, Sallan SE, Bradner JE, French CA. Chau NG, et al. Among authors: french ca. Cancer. 2016 Dec 1;122(23):3632-3640. doi: 10.1002/cncr.30242. Epub 2016 Aug 10. Cancer. 2016. PMID: 27509377 Free PMC article.
NUT Carcinoma of the Sublingual Gland.
Andreasen S, French CA, Josiassen M, Hahn CH, Kiss K. Andreasen S, et al. Among authors: french ca. Head Neck Pathol. 2016 Sep;10(3):362-6. doi: 10.1007/s12105-015-0672-7. Epub 2015 Nov 19. Head Neck Pathol. 2016. PMID: 26586234 Free PMC article.
Nuclear protein in testis midline carcinoma misdiagnosed as adamantinoma.
Puliyel MM, Mascarenhas L, Zhou S, Sapra A, Dal Cin P, French CA, Venkatramani R. Puliyel MM, et al. Among authors: french ca. J Clin Oncol. 2014 May 20;32(15):e57-60. doi: 10.1200/JCO.2012.48.5300. Epub 2014 Jan 27. J Clin Oncol. 2014. PMID: 24470009 Free PMC article. No abstract available.
NUT midline carcinoma: an aggressive intrathoracic neoplasm.
Parikh SA, French CA, Costello BA, Marks RS, Dronca RS, Nerby CL, Roden AC, Peddareddigari VG, Hilton J, Shapiro GI, Molina JR. Parikh SA, et al. Among authors: french ca. J Thorac Oncol. 2013 Oct;8(10):1335-8. doi: 10.1097/JTO.0b013e3182a00f41. J Thorac Oncol. 2013. PMID: 24457244 Free article.
The importance of diagnosing NUT midline carcinoma.
French CA. French CA. Head Neck Pathol. 2013 Mar;7(1):11-6. doi: 10.1007/s12105-013-0428-1. Epub 2013 Mar 5. Head Neck Pathol. 2013. PMID: 23463074 Free PMC article. Review.
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
Lee CH, Ou WB, Mariño-Enriquez A, Zhu M, Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, West RB, McAlpine JN, Gilks CB, Yaffe MB, Prentice LM, McPherson A, Jones SJ, Marra MA, Shah SP, van de Rijn M, Huntsman DG, Dal Cin P, Debiec-Rychter M, Nucci MR, Fletcher JA. Lee CH, et al. Among authors: french ca. Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):929-34. doi: 10.1073/pnas.1115528109. Epub 2012 Jan 5. Proc Natl Acad Sci U S A. 2012. PMID: 22223660 Free PMC article.
A rare case of NUT midline carcinoma.
Ball A, Bromley A, Glaze S, French CA, Ghatage P, Köbel M. Ball A, et al. Among authors: french ca. Gynecol Oncol Case Rep. 2012 Oct 8;3:1-3. doi: 10.1016/j.gynor.2012.09.004. eCollection 2012. Gynecol Oncol Case Rep. 2012. PMID: 24371650 Free PMC article.
Pathogenesis of NUT midline carcinoma.
French CA. French CA. Annu Rev Pathol. 2012;7:247-65. doi: 10.1146/annurev-pathol-011811-132438. Epub 2011 Oct 17. Annu Rev Pathol. 2012. PMID: 22017582 Review.
Differentiation of NUT midline carcinoma by epigenomic reprogramming.
Schwartz BE, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH, Agoston ES, Reynoird N, Khochbin S, Ince TA, Christie A, Janeway KA, Vargas SO, Perez-Atayde AR, Aster JC, Sallan SE, Kung AL, Bradner JE, French CA. Schwartz BE, et al. Among authors: french ca. Cancer Res. 2011 Apr 1;71(7):2686-96. doi: 10.1158/0008-5472.CAN-10-3513. Epub 2011 Mar 29. Cancer Res. 2011. PMID: 21447744 Free PMC article.
NUT midline carcinoma.
French CA. French CA. Cancer Genet Cytogenet. 2010 Nov;203(1):16-20. doi: 10.1016/j.cancergencyto.2010.06.007. Cancer Genet Cytogenet. 2010. PMID: 20951314 Free PMC article. Review.
Midline carcinoma of children and young adults with NUT rearrangement.
French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, Miyoshi I, Perez-Atayde AR, Aster JC, Fletcher JA. French CA, et al. J Clin Oncol. 2004 Oct 15;22(20):4135-9. doi: 10.1200/JCO.2004.02.107. J Clin Oncol. 2004. PMID: 15483023
Genetic and biological subgroups of low-stage follicular thyroid cancer.
French CA, Alexander EK, Cibas ES, Nose V, Laguette J, Faquin W, Garber J, Moore F Jr, Fletcher JA, Larsen PR, Kroll TG. French CA, et al. Am J Pathol. 2003 Apr;162(4):1053-60. doi: 10.1016/S0002-9440(10)63902-8. Am J Pathol. 2003. PMID: 12651598 Free PMC article.